Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...

A study in weight loss drugs where one third of participants were given a placebo turned out to have some impressive results.

People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy.

Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly.

When considering a weight loss medication — or any medication — it’s normal to wonder when the effects will kick in.

Many people using GLP-1 weight-loss drugs like Ozempic, Wegovy or Mounjaro regain the weight after stopping-experts explain ...

Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.

Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...

The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide ...

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

On a weekday morning in Dublin, a group of patients walked into a weight-loss clinic hoping to shed pounds. What they didn’t ...

There is growing evidence that Ozempic and other GLP-1 receptor agonist drugs might help people drink less alcohol, but more ...